Toxicity and survival associated with IV/IP chemotherapy following neoadjuvant chemotherapy and interval debulking surgery for epithelial ovarian, fallopian tube, and primary peritoneal cancer

被引：0
|
作者：
Rios-Doria, E. [1 ]
Pezzillo, M. [1 ]
Ulm, M. A. [2 ]
Tillmanns, T. [2 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[2] Univ Tennessee, West Canc Ctr, Memphis, TN USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.157
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
269
引用
收藏
页码：127 / 128
页数：2
相关论文
共 50 条
  • [21] PROGRESSION FREE SURVIVAL COMPARISON WITH NEOADJUVANT CHEMOTHERAPY AND PRIMARY DEBULKING SURGERY IN ADVANCED EPITHELIAL OVARIAN CANCER
    Lee, Y. J.
    Kim, Y. M.
    Lee, S. H.
    Park, J. Y.
    Suh, D. S.
    Kim, D. Y.
    Kim, J. H.
    Kim, Y. T.
    Nam, J. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1416 - 1416
  • [22] Impact of delay in interval debulking surgery after neoadjuvant chemotherapy on survival in ovarian cancer
    Khalil, Kheyal Azam
    Habib, Maria
    Saeed, Afshan
    Syed, Aamir Ali
    Anwer, Abdul Wahid
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A284 - A285
  • [23] Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
    Liu, Ying L.
    Zhou, Qin
    Iasonos, Alexia
    Filippova, Olga T.
    Chi, Dennis
    Zivanovic, Oliver
    Sonoda, Yukio
    Gardner, Ginger J.
    Broach, Vance
    O'Cearbhaill, Roisin Eilish
    Konner, Jason A.
    Aghajanian, Carol
    Long-Roche, Kara C.
    Tew, William P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Neoadjuvant chemotherapy followed by interval debulking surgery versus primary debulking surgery in the advanced epithelial ovarian cancer - a retrospective cohort study
    Maricic, Slobodan
    Mandic, Aljosa
    Dejanovic, Ninoslav
    Kladar, Nebojsa
    Popovic, Marina
    Ivkovic-Kapicl, Tatjana
    Gutic, Bojana
    Kokanov, Dunja
    VOJNOSANITETSKI PREGLED, 2021, 78 (11) : 1193 - 1199
  • [25] Impact of delay in interval debulking surgery after neoadjuvant chemotherapy on survival in ovarian cancer
    Khalil, Kheyal Azam
    Habib, Maria
    Usmani, Afshan Saeed
    Shah, Muhammad Ansab
    Anwer, Abdul Wahid
    Syed, Aamir Ali
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2025, 75 (04) : 583 - 586
  • [26] NEOADJUVANT CHEMOTHERAPY AND INTERVAL DEBULKING FOR ADVANCED EPITHELIAL OVARIAN-CANCER
    JACOB, JH
    GERSHENSON, DM
    MORRIS, M
    COPELAND, LJ
    BURKE, TW
    WHARTON, JT
    GYNECOLOGIC ONCOLOGY, 1991, 42 (02) : 146 - 150
  • [27] Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer
    Nishio, Shin
    Ushijima, Kimio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 379 - 386
  • [28] Survival and toxicity of a modified GOG 172 IP chemotherapy regimen in patients with ovarian, fallopian tube or primary peritoneal carcinoma
    Becker, D.
    Haygood, C. L. Walters
    Smith, B.
    Bevis, K. S.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 176 - 177
  • [29] Primary debulking surgery versus neoadjuvant chemotherapy in elderly patients with epithelial ovarian cancer
    Xu, Z.
    Justiniano, C. F.
    Fleming, F. J.
    Boscoe, F. P.
    Schymura, M. J.
    Rubinsak, L. A.
    Morrow, G.
    Minasian, L.
    Temkin, S. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 78 - 78
  • [30] Delay in interval debulking surgery after neoadjuvant chemotherapy in ovarian cancer
    Habib, M.
    Khalil, K. Azam
    Saeed, A.
    Usman, M.
    Khattak, S.
    Syed, A. Ali
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 51 - 51
12345